Table 3. Human papillomavirus vaccination coverage survey, survey respondents and girls eligible for vaccination, India, Peru, Uganda and Viet Nam, 2008–2010.
Vaccine delivery strategy | Peru |
Uganda |
Viet Nam |
India |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
School-based |
School-based |
Combined with Child Days Plus programme |
School-based |
Health-centre-based |
School- and health-centre-based, pulsed campaign at three time points |
School- and health centre-based, monthly delivery |
||||||||||
2008 | 2008 | 2009 | 2008–2009 | 2009 | 2008–2009 | 2009–2010 | 2008–2009 | 2009–2010 | 2009–2010 | 2009–2010 | ||||||
Respondents, no. | 575 | 400 | 280 | 361 | 448 | 500 | 285 | 280 | 219 | 1948 | 1973 | |||||
Mother, no. (%) | 421 (74) | 243 (61) | 151(54) | 225 (63) | 272 (61) | 346 (69) | 177 (63) | 200 (71) | 123 (57) | 1246 (64) | 1147 (58) | |||||
Father, no. (%) | 44 (8) | 89 (23) | 74 (26) | 52 (14) | 70 (16) | 65 (13) | 64 (23) | 58 (21) | 71 (33) | 437 (22) | 449 (23) | |||||
Other adult relative, no. (%) | 105 (18) | 46 (12) | 36 (13) | 52 (14) | 84 (19) | 53 (11) | 29 (11) | 14 (5) | 15 (7) | 231 (12) | 374 (19) | |||||
Other adult, no. (%) | 1 (< 1) | 18 (5) | 19 (7) | 30 (8) | 21 (5) | 36 (7) | 13 (5) | 8 (3) | 8 (4) | 34 (2) | 3 (< 1) | |||||
Age of eligible girl,a,b no. (%) | ||||||||||||||||
< 10 years | 16 (3) | 5 (1) | 3 (1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
10 years | 257 (45) | 18 (5) | 21 (8) | 361 (100) | 448 (100) | 22 (4) | 27 (9) | 29 (10) | 26 (12) | 123 (6) | 130 (6) | |||||
11 years | 198 (34) | 38 (10) | 42 (15) | 0 | 0 | 150 (30) | 126 (44) | 188 (67) | 137 (63) | 394 (20) | 350 (18) | |||||
12 years | 69 (12) | 79 (20) | 40 (14) | 0 | 0 | 2 (< 1) | 5 (2) | 0 | 0 | 538 (28) | 446 (23) | |||||
13 years | 20 (3) | 101 (25) | 63 (23) | 0 | 0 | 1 (< 1) | 0 | 0 | 0 | 495 (25) | 488 (25) | |||||
14 years | 9 (2) | 88 (22) | 55 (20) | 0 | 0 | 0 | 0 | 0 | 0 | 398 (20) | 559 (28) | |||||
> 14 years | 6 (1) | 66 (17) | 30 (11) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
School grade of eligible girl,a,b,c no. (%) | ||||||||||||||||
Not regularly attending school | 0 | 0 | 0 | 0 | 2 (< 1) | 0 | 0 | 0 | 0 | 179 (9) | 505 (26) | |||||
Grade 1 or 2 | 0 | 0 | 0 | 70 (19) | 96 (21) | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Grade 3 | 0 | 0 | 0 | 156 (43) | 162 (36) | 0 | 0 | 0 | 0 | 4 (< 1) | 8 (< 1) | |||||
Grade 4 | 0 | 0 | 0 | 91 (25) | 120 (27) | 2 (< 1) | 1 (< 1) | 1 (< 1) | 1 (< 1) | 34 (2) | 45 (2) | |||||
Grade 5 | 575 (100) | 400d (100) | 280 (100) | 33 (9) | 46 (10) | 10 (2) | 11 (4) | 12 (4) | 6 (3) | 173 (9) | 168 (9) | |||||
Grade 6 | 0 | 0 | 0 | 7 (2) | 8 (2) | 472 (94) | 268 (94) | 256 (91) | 207 (95) | 369 (19) | 338 (17) | |||||
Grade 7 | 0 | 0 | 0 | 0 | 0 | 1 (< 1) | 0 | 5 (2) | 0 | 412 (21) | 354 (18) | |||||
Grade 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 338 (17) | 265 (13) | |||||
Above grade 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 439 (23) | 289 (15) |
a At administration of the first vaccine dose, as reported by survey respondents.
b The totals may not add up to 100% of all respondents because some data on age, date of birth, school enrolment or school grade were missing.
c The term “grade” has been adopted generically even though India uses the term “standard”, Peru and Viet Nam use the term ”grade” and Uganda uses the term ”class”, all which have the same meaning.
d School grades were missing for four girls but were assumed to be grade five.